Skip to main content

Advertisement

Table 2 Association of miR-339-5p expression with clinicopathological data from breast cancer patients

From: MiR-339-5p inhibits breast cancer cell migration and invasion in vitro and may be a potential biomarker for breast cancer prognosis

Variable n MiR-339-5p expression, n(%) Pvalue
Age (years)    
   ≤35 6 0 (0) 0.12
   35-55 48 18 (37.5)  
   > 55 36 9 (25.0)  
Tumor size (cm)    
   ≤2 4 2 (50.0) 0.67
   2-5 68 20 (29.4)  
   > 5 18 5 (27.8)  
Lymph node metastases    
   0 29 14 (48.3) 0.018
   1-3 33 9 (27.3)  
   > 3 28 4 (14.3)  
Grade    
   I 4 1 (25.0) 0.17
   II 57 21 (36.8)  
   III 29 5 (17.2)  
Stage    0.005
   I - II 50 21 (42.0)  
   III - IV 40 6 (15.0)  
Estrogen receptor    
   - 57 18 (36.1) 0.67
   + 33 9 (27.3)  
Progesterone receptor    
   - 56 16 (28.6) 0.70
   + 34 11 (32.4)  
c-erbB-2 expression    
   Low 59 18 (30.5) 0.89
   High 31 9 (29.0)